John Hawley

Nominations for Honorary membership, 2022

Posted on by John Hawley

Nominations for 2022 Honorary membership are open and may be submitted through January 26, 2022, 11:59 pm Eastern. The ASCI bylaws provide the following guidance regarding nominations to Honorary membership:

Any distinguished person who has contributed significantly to the Society’s objectives, who has not been previously and unsuccessfully nominated for Active or International membership, and who enjoys an unimpeachable moral standing is eligible for nomination in this category. A nomination in this category may be proposed by any member (including members of the Council) in good standing, and must be accompanied by a list of the nominee’s achievements and a statement regarding the significance of the nominee’s contributions. The Council shall recommend to election a total not to exceed ten, which is separate from the limit for Active and International recommendations.

Proposers and supporters of nominations should carefully review the information below. Questions should be sent by email to staff@the-asci.org.

To ensure proper tracking of nominations, all information and documents must be supplied online.

To begin:

  • Access your member account.
  • In the “Nominations” area, see “Nominations for Honorary membership, 2022”.
  • Click “Start nomination” and follow the guidance to select your role (Proposer or General Supporter) and provide the nominee’s name.

Proposers:

Proposers are responsible for ensuring that all information provided for the nomination is accurate and complete. A Proposer may grant the nominee access to edit certain sections of the nomination, as detailed below.

The ASCI acknowledges and confirms a nomination by email after a review of the information supplied to ensure the nominee is eligible and that the nomination is complete.

Nomination sections:

  • About the nominee — nominee may edit this information.
  • Nominee’s demographic information — nominee may edit this information. The ASCI requests responses to 9 sections that will help provide the foundation for expanding diversity, fostering inclusion, and achieving equity in the ASCI. All response areas are voluntary, with a “Prefer not to answer” option available for each section. Anyone with access to person-specific information (such as ASCI leadership, members associated with review processes, and staff members) will be required to keep the information confidential. Depersonalized summary information of all response areas may be provided in periodic public reports.
  • Support for nomination — must be completed by the Proposer (only accessible to the Proposer). Proposers may attach General Supporters (limit of 3 per nomination) to the nomination by searching the ASCI member directory or by adding information for supporters who are not ASCI members.
  • Nominee’s institutional affiliation — nominee may edit this information
  • Documents — nominee may edit this information:
    • Full academic curriculum vitae, including full bibliography (with original research separated from other types of publications) and invited lectures. In the bibliography, ensure that the nominee’s name is presented in bold face.
    • NIH-style biographic sketch (5-page limit), following the current format available at:
      http://grants.nih.gov/grants/forms/biosketch.htm
      Information about current independent grant support, indicating clearly whether the nominee is a principal investigator, should be noted, so that the Council has standardized information regarding all nominees. Independent research support represents one of several criteria used in assessing independence.
    • PDFs of publications noted in “Most significant publications” section below.
  • Most significant publications —  nominee may edit this information. List the nominee’s 3 most significant publications, excluding those representing work done by the nominee as a trainee, and provide annotation for each (limit of 50 words) describing the publication’s key findings and significance. Present authors in the original publication sequence, with the nominee’s name in capital letters, followed by numbered notation of the nominee’s role in parentheses (1 for principal investigator, 2 for collaborator), title, journal name, volume, inclusive page numbers, and year. For example: John Q. Public and JANE DOE (1). Title. Journal. 1:1-10 (2015).
  • Seminal contribution —  nominee may edit this information. Summarize the nominee’s defining seminal contribution(s) and why this work forms the basis for the nomination. 75-word limit.
  • Proposer’s general statement on the nominee —  must be completed by the Proposer. In the Proposer’s own words, describe the quality, originality, and impact of the nominee’s scientific work and the consistency and importance of the nominee’s research theme. Include a statement on the level of independence from the nominee’s mentor(s) and the nominee’s productivity and stature in the field. 500-word limit. Proposers should expand upon the candidate’s seminal contribution(s), including the originality, novelty, and impact of this research on the field. Note any special circumstances (e.g., childbearing, personal or family illness) that influenced the candidate’s research activities. Information regarding major awards, invitations to give plenary lectures (especially at national and international meetings), and invitations to write chapters in major textbooks should be included as applicable — the quality and quantity of work are important factors.

General Supporters

The General Supporter who is an ASCI member should following the guidance above in the “To begin” section to complete a support form online. General Supporters who are not ASCI members may complete the nomination support template and email it to staff@the-asci.org for handling.

Call for nominations, 2022 Seldin~Smith Award

Posted on by John Hawley

The ASCI is pleased to call for nominations for the 2022 Donald Seldin~Holly Smith Award for Pioneering Research. The Award seeks to recognize and connect the next generation of physician-scientist leaders with the legacies of two of the ASCI’s most esteemed members, Drs. Donald W. Seldin and Lloyd H. “Holly” Smith Jr.

For the Award, the ASCI seeks nominations of outstanding physician-scientists who have demonstrated exceptional creativity and accomplishments in biomedical research. The ideal nominee:

  • is an early-stage, clinically active physician-scientist addressing fundamental questions that relate to human health and disease, and
  • shows great promise in biomedicine.

The recipient of the Seldin~Smith Award will receive an unrestricted grant of $30,000 to advance academic efforts. S/he will be recognized at the 2022 AAP/ASCI/APSA Joint Meeting, deliver a research talk at the 2023 Joint Meeting, and receive mentoring from the members of the Seldin~Smith Award Selection Committee and Advisory Committee.

Eligibility

  • MD (or the equivalent) or MD/PhD;
  • The candidate must be more than 2 years but not more than 6 years from first faculty (or the equivalent) appointment at the time of acceptance in April 2022;
  • The candidate spends substantial time in research while providing direct patient care.

This competition is not restricted to any geographic location.

Note that while those who are already ASCI members may be nominated (provided they meet the preceding eligibility criteria), we encourage nominations of those who are not yet members, in order to best represent the promise of early-stage physician-scientists that this award is intended to recognize.

Application

Physician-scientists should apply directly by sending nominations by email attachments to staff@the-asci.org.

  • Completed nomination form, including:
    • a summary of the nominee’s research (not to exceed 100 words)
    • a description of the nominee’s most significant achievement (not to exceed 500 words).
    • a list of the nominee’s three most significant publications and a short statement describing the significance of each publication (not to exceed 100 words each).
    • Nominee’s agreement, if chosen as the recipient, to attend the 2022 AAP/ASCI/APSA Joint Meeting (April 8-10) and the 2023 AAP/ASCI/APSA Joint Meeting (April 21-23).
  • PDFs of the nominee’s three most significant publications as listed in the nomination form.
  • Nominee’s curriculum vitae (PDF). Include only educational background, major awards, and peer-reviewed publications (do not include abstracts, grants, or meeting presentations).
  • No more than two letters of support (as PDFs), one from the nominee’s primary mentor, the other ideally from an individual who is a recognized expert on the subject of the nominee’s research.

Notable dates and selection process

  • Nomination deadline: February 3, 2022 (extended from January 26, 2022).
  • Recipient will be notified early March 2022.
  • Recipient will be recognized at the 2022 AAP/ASCI/APSA Joint Meeting, April 8-10.
  • Recipient will deliver a research talk at the 2023 AAP/ASCI/APSA Joint Meeting, April 21-23.

The Seldin~Smith Award Selection Committee reviews nominations and selects finalists for further consideration by the Seldin~Smith Award Advisory Committee.

Elizabeth McNally, MD, PhD, elected 2022-2027 JCI Editor-in-Chief

Posted on by John Hawley

 

Dr. McNally

Elizabeth McNally, MD, PhD, has been elected as the 2022-2027 Editor-in-Chief of the Journal of Clinical Investigation (JCI). She will succeed Rexford Ahima, MD, PhD, who has served as the journal’s Editor-in-Chief since July 2018. Dr. McNally’s term begins March 1, 2022.

Dr. McNally is the Director for the Center for Genetic Medicine at the Northwestern University Feinberg School of Medicine. Dr. McNally studies inherited disorders that affect cardiac and skeletal muscle function. Her efforts have elucidated membrane-associated defects that disturb cellular integrity and repair mechanisms leading to the identification of therapeutic targets. Dr. McNally was elected to the ASCI in 2003 and served as President, 2011-2012. She was elected to the Association of American Physicians in 2006 and is serving as the 2021-2022 President. She was elected to the American Academy of Arts and Sciences and the National Academy of Medicine in 2021.

“The JCI publishes a broad range of molecular medicine, including new therapeutic mechanisms,” Dr. McNally said. “We have a tremendous depth of expertise here at Feinberg, and we will be drawing on our outstanding scientists to guide the Journal over these next 5 years. It’s really an honor for us at Northwestern and speaks to the growth we’ve had as a medical school.”

“I was honored to serve as Chair of the Editor Selection Committee, which devoted itself to selecting the best candidate to succeed Dr. Ahima and a long list of esteemed Editors-in-Chief,” said Sohail Tavazoie, MD, PhD, the ASCI’s 2021-2022 President-Elect. “I was particularly proud to be a part of the outstanding group who selected Dr. McNally, who will become the first woman to serve as the Editor-in-Chief of JCI.”

Dr. McNally’s Editorial Board will include Deputy Editors Hossein Ardehali, MD, PhD (elected to ASCI in 2012); Daniel Brat, MD, PhD (2014); Alfred George, Jr., MD (1998); Maha Hussain, MD; and Susan Quaggin, MD (2006). The following will serve as Associate Editors: Sarki Abdulkadir, MD, PhD (2017); Marisa-Luisa Alegre, MD, PhD (2006); Rishi Arora, MD (2020); Joe Bass, MD, PhD; Ankit Bharat, MBBS (2019); GR Scott Budinger, MD (2014); Serdar Bulun, MD (2003); Navdeep Chandel, PhD; Eugene Chang, MD (1992); Jaehyuk Choi, MD, PhD (2021); Richard D’Aquila, MD; Stephanie Eisenbarth, MD, PhD (2020); Amy Heimberger, MD, PhD (2011); Luisa Iruela-Arispe, PhD; Peng Ji, PhD; Igor Koralnik, MD (2008); Maciej Lesniak, MD (2018); Hidayatullah Munshi, MD (2012); Marcelo Nobrega, MD, PhD (2015); Guillermo Oliver, PhD; Puneet Opal, MD, PhD (2013); John Pandolfino, MD (2018); Sachin Patel, MD, PhD (2018); Laura Rasmussen-Torvik, PhD; Patrick Seed, MD, PhD; and Ali Shilatifard, PhD.

The ASCI thanks the members of the Editor Selection Committee for their service: Dr. Tavazoie, Chair (The Rockefeller University), Rexford S. Ahima, MD, PhD (Johns Hopkins University School of Medicine), Kathleen L. Collins, MD, PhD (University of Michigan Medical School), Benjamin D. Humphreys, MD, PhD (Washington University School of Medicine in St. Louis), Priscilla Hsue, MD (University of California, San Francisco, School of Medicine), Martin G. Myers, Jr., MD, PhD (University of Michigan Medical School), M. Bishr Omary, MD, PhD (Rutgers, Robert Wood Johnson Medical School), and Robert H. Vonderheide, MD, DPhil (University of Pennsylvania Perelman School of Medicine).

In November, the ASCI’s Active members were asked to vote on the recommendation of Dr. McNally as the 2022-2027 Editor in Chief. Following the bylaw’s Ballot Review Committee section, the results of the vote were received, reviewed, and verified by Priscilla Hsue (2021-2023 ASCI Secretary-Treasurer) and two Active members identified by random selection from ballots submitted and who agreed to audit the results. The ASCI thanks Ekihiro Seki, MD, PhD, and Jeremy Veenstra-VanderWeele, MD, for their service as auditors.

Nominations for ASCI Council, 2022

Posted on by John Hawley

The Society seeks nominations for the following ASCI Council vacancies arising in 2022 (all terms begin and end in the spring):

  • Vice President (4-year term, 2022-2026),
  • Secretary-Treasurer Elect (3-year term, 2022-2025; first year is Councilor position, transitioning to Secretary-Treasurer for years 2 and 3), and
  • a Councilor position (3-year term, 2022-2025).

Members who will be 55 or younger in 2025 are eligible for nomination (self-nominations are not permitted). The Society strongly encourages members to consider diversity in identifying those suitable for nomination. Nominations may be submitted by any member and must be submitted by February 3, 2022, at 11:59 PM EST.

All Council members are expected to support the activities of and attend the ASCI annual meeting, and to participate in the general governance of the Society, including two in-person meetings (fall and spring, with the spring meeting occurring as part of the annual meeting) and conference calls (typically every other month). All Council members participate in the review of membership nominations.

The Vice President transitions to President-Elect in year 2, President in year 3, and Immediate Past President in year 4. For the 2nd through 4th years of this position, this member is expected to participate significantly in matters related to the annual meeting. In the Presidential year (year 3), the member convenes a face-to-face Council meeting and oversees related review processes for nominations, notably including those to membership. The President works closely with the Association of American Physicians to create the annual meeting program and presents the traditional Presidential Address at the meeting.

The Council is supported by an Executive Director, Managing Director, and other staff members who oversee the day-to-day operations of the Society and effect initiatives as directed by the Council. For details on Officers and Councilors, see the ASCI Bylaws.

The nominator is responsible for providing the following through her/his member account:

  • a 250-word summary of the nominee’s accomplishments
  • the nominee’s NIH-style brief biosketch (PDF)
  • the vacancy for which the nominee wishes to be considered

The nominee is responsible for providing a 250-word candidate statement, written in first person, for consideration by the Council and for use as the ballot statement if the nominee is selected as a candidate. The nominee must provide the statement by email to staff@the-asci.org by the deadline noted above. (Nominees may refer to candidate statements for the 2021 nomination cycle for guidance in drafting their own statements.)

Diversity, Equity, and Inclusion Committee update — December 2021

Posted on by John Hawley
Dr. Paczesny

As we approach the first anniversary of the convening of the Diversity, Equity, and Inclusion Committee (DEIC), I am pleased to share with you the Committee’s accomplishments.

The ASCI bylaws state that the DEIC “ensures that the organization, its programs, and its mentoring mechanisms promote and recognize diversity, inclusion, and equity.”

With these goals in mind, the Committee has developed foundational documents, the first of which is intended to establish a common understanding of key terms. This text outlines the considerations underlying the definitions of diversity, equity, and inclusion, and presents the term underrepresented in medicine and science (UiMS) in reference to populations that are underrepresented in medicine and science relative to their numbers in the general US population.

The second is the Society’s effort to collect detailed demographic information. We started this collection as part of the 2022 member nomination process  — our first data set. From here, we will endeavor to collect this information in all areas of the ASCI.

You can now provide your demographic details through your member account. The data collected will allow us to determine the current makeup of the Society’s populations, areas needing attention, and changes over time. Information will be kept confidential, and data will be deidentified for any reporting. All response areas are voluntary. We welcome your feedback (via staff@the-asci.org) and will incorporate changes as appropriate.

I look forward to bringing you news of further steps the Committee and the ASCI undertake in the areas of diversity, equity, and inclusion.

Sincerely on behalf of the Committee,

Sophie Paczesny, MD, PhD
Chair, Diversity, Equity, and Inclusion Committee

Call for nominations, 2022 Emerging Generation Awards

Posted on by John Hawley

Nominations for the ASCI’s 2022 Emerging Generation (E-Gen) Awards are open through December 20, 2021, at 11:59 pm Eastern, the deadline for submission.

The E-Gen Awards recognize post-MD, pre-faculty appointment physician-scientists who are meaningfully engaged in immersive research, giving them access to the Joint Meeting and longitudinal programming over a 2-year period. Entry into the ASCI network at this stage is intended to provide peer support and inspiration to stay the course into a physician-scientist faculty appointment. Up to 20 Awardees will be selected.

The nominee for this recognition:

  • will have demonstrated creative promise during research training
  • is at least 3 years post MD
  • is meaningfully engaged in immersive research
  • must be nominated by an ASCI member
  • must provide a separate 250-word articulation of her/his scientific vision, by email to programs@the-asci.org with a notation regarding who is serving as the nominating ASCI member.

The nominating member must provide the following through her/his member account:

  • a completed nomination form (download Word document), including:
    • a 250-word nominating statement summarizing the nominee’s accomplishments
    • (optional) information about a supporting ASCI member who can be contacted regarding the nomination
  • the nominee’s NIH-style biosketch
  • the nominee’s completed ASCI demographics survey (download PDF)

Contact programs@the-asci.org with any questions.

Call for nominations, 2022 Stanley J. Korsmeyer Award

Posted on by John Hawley

Nominations for the ASCI’s 2022 Stanley J. Korsmeyer Award are now open. This prestigious recognition, first called the ASCI Award, was renamed in 2006 in honor of Dr. Korsmeyer, the first recipient of the Award in 1998, who passed away in 2005. The Korsmeyer Award recognizes individuals for their advancement of knowledge in a specific field and mentoring of future generations of life science researchers. Information on all past honorees is available here.

Nominees for the Stanley J. Korsmeyer Award must be ASCI members who are 55 years of age or younger as of January 1, 2022. They shall have made significant contributions to biomedical science and shall have adhered to the principles of scientific excellence that the ASCI exemplifies. The nominee should have a record that reflects high standards of intellectual integrity, a deep and abiding respect for the community of biomedical scientists, and a strong commitment to mentoring the next generation of physician-scientists. Prior nominees may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.

Nominations consist of:

  • a summary of the nominee’s accomplishments (in plain text, not to exceed 250 words),
  • a brief NIH biosketch (as a PDF),
  • a full curriculum vitae, including all publications and invited lectures (as a PDF),
  • and a trainee table (preferred as a PDF).

Nominations must be submitted by ASCI members through their online accounts.

The deadline for nominations is October 7, 2021, at 11:59 PM Eastern.

Nominations for Active and International membership, 2022

Posted on by John Hawley

Nominations for 2022 membership may be submitted through October 4, 2021, 11:59 pm Eastern. Proposers and supporters of nominations should review the guide below carefully. Questions regarding nominations should be sent by email to staff@the-asci.org.

  • Nomination guide for Active and International membership (PDF). This document should be reviewed for details about the process and to ensure a complete nomination. Note: As of the 2021 cycle, a separate nomination form was eliminated, in favor of an interactive web-based process.
  • Membership nomination support template (for use by Seconders and General Supporters; Word document). This document provides a template for drafting nomination support. However, members are encouraged to submit scores and comments through their member accounts (this template matches the online form).

Submitting nominations

To ensure proper tracking of nominations, all information and documents must be supplied online.

  • To begin, access your member account
  • After you have logged in to your account, select the “Nominations” tab, then search the nominee database. Links will appear in search results to guide you in the next steps.
  • Your nominee may already be in the ASCI database because the person was previously nominated or because a nomination or support form has been started for this nomination cycle.

Proposers: Proposers are responsible for ensuring that all information provided for the nomination is accurate and complete. A Proposer may grant access to a nominee to edit certain sections of the nomination (see the guide above for details).

In their accounts, Proposers are able to identify those serving as Seconder and General Supporters of the nomination, although supporters need to provide comments via their own member accounts.

ASCI staff sends acknowledgment of submissions by email after they have been reviewed and found to be complete. Proposers can check the status of their submissions (nominations and support forms) online by accessing their member accounts.

Seconder and General Supporters: To draft and complete forms online, select the nominee from search results; or add the requested information about the nominee you are supporting. General Supporters who are not ASCI members may complete the nomination support template and email it to staff@the-asci.org for handling.

Further clarification

  • Age criterion for Active and International nominees. Nominees in these categories must be age 50 or younger as of January 1, 2022.
  • Exceptions to the age criterion cannot be made. Although the ASCI Council understands that a nominee’s progress may have been delayed because of unavoidable or extreme circumstances, the Council has on multiple occasions discussed exceptions and concluded from each discussion that no policy could be implemented fairly and durably.
  • Limit on number of nominations per nominee. The number of nominations per nominee is limited to 3, provided the nominee is age 50 or younger as of January 1, 2022.
  • Limit on number of nominations proposed, seconded, or supported. There is no limit to the number of nominations a member may propose or support (either as Seconder or General Supporter).
  • PhD-only candidates. Active and International nominations are, per the ASCI’s bylaws, restricted to physicians.
  • MD-equivalent candidates are eligible for nomination.
  • Faculty appointment versus nominee’s country of residence. The distinction between Active and International nominations is made on the basis of residence, not faculty appointment. Active nominees must reside in the US or Canada. Candidates residing elsewhere should be nominated in the International category.

Voters approve bylaws amendments regarding membership nominations and other items

Posted on by John Hawley

A ballot was issued to Active voters on July 12, 2021, that proposed the following changes to the organization’s bylaws:

“Article II – Objectives”: remove outdated description of the Society’s publications, “… for national and international distribution, on subscription at prices not in excess of calculated expenses and needs, …”

“Article III – Membership, Section 2, Membership nomination and election”:

  1. Increase the annual limit for Active and Foreign Associate candidates recommended for election, from 80 to 100.
  2. Re-establish the Honorary membership nomination category as distinct from the Active and Foreign Associate category, with an annual limit of 10 for election via a distinct ballot item.
  3. Allow Foreign Associate members to vote on membership recommendations.
  4. Allow Emeritus and Honorary members to serve as proposers and seconders of membership nominations.

Rename “Foreign Associate” members to “International” throughout the bylaws.

By the July 19, 2021, deadline, 44.7% of eligible voters responded, reaching the minimum 40% participation rate required for ballot items regarding bylaws amendments. For each proposed amendment, the percentage of voters who responded favorably was over the 75% threshold required to approve amendments.

Following the bylaw’s Ballot Review Committee section, these results were received, reviewed, and verified by Priscilla Hsue (2021-2023 ASCI Secretary-Treasurer) and two Active members identified by random selection from ballots submitted and who agreed to audit the results. Thank you to Joseph R. Arron, MD, PhD (Genentech) and Ravi Thadhani, MD, MPH (Mass General Brigham) for their service.

Nominations open for 9th annual Harrington Prize for Innovation in Medicine

Posted on by John Hawley

Harrington Discovery Institute and the ASCI collaborate to recognize an outstanding achievement of a physician-scientist globally

National and international nominations are being sought for the 2022 Harrington Prize for Innovation in Medicine, which honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity and the potential for clinical application. 

The Harrington Prize, which carries a $20,000 honorarium, is a collaboration between the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio—part of The Harrington Project for Discovery & Development—and the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected medical honor societies. The Harrington Discovery Institute is a nonprofit institute dedicated to helping physicians and scientists advance promising discoveries into medicines for unmet needs.

Both organizations recognize the challenges associated with translating discoveries into medicines, and they are eager to highlight those who have navigated the path successfully or whose work has led to novel treatments.

A committee composed of members of the Harrington Discovery Institute Scientific Advisory Board and the ASCI Council will review the nominations and select the awardee. In addition to the honorarium, the 2022 recipient will deliver the Harrington Prize Lecture at the 2022 Joint Meeting of the Association of American Physicians (AAP), the ASCI, and the American Physician Scientists Association (APSA); will lecture at the 2022 Harrington Discovery Institute Symposium; and will publish a personal essay in the Journal of Clinical Investigation.

Submitting a Nomination:

  • The deadline for nominations is September 29, 2021 (extended from September 20).
  • Multiple nominations from an institution are welcomed.
  • Teams are accepted for a nomination, but a primary nominee is required.
  • Nomination guidelines can be found at HarringtonDiscovery.org/ThePrize.

Previous Harrington Prize recipients:

  • 2014: Harry Dietz, MD, Johns Hopkins University, for his contributions to the understanding of the biology and treatment of Marfan syndrome, a disorder leading to deadly aneurysms in children and adults.
  • 2015: Douglas R. Lowy, MD, The National Cancer Institute, in recognition of his discoveries that led to the development of the Human Papillomavirus vaccine to prevent cervical cancer.
  • 2016: Jeffrey M. Friedman, MD, PhD, The Rockefeller University, for his discovery of leptin, which controls feeding behavior and is used to treat related clinical disorders.
  • 2017: Jointly awarded to Daniel J. Drucker, MD, Mount Sinai Hospital, Canada, Joel F. Habener, MD, Massachusetts General Hospital, and Jens J. Holst, MD, DMSc, University of Copenhagen, Denmark, for their discovery of incretin hormones and for the translation of these findings into transformative therapies for major metabolic diseases such as diabetes.
  • 2018: Helen H. Hobbs, MD, UT Southwestern Medical Center, for the discovery of the link between a gene mutation (PCSK9) and lower levels of LDL, which has improved the treatment of high cholesterol.
  • 2019: Carl H. June, MD, University of Pennsylvania, for advancing the clinical application of CAR T therapy for cancer treatment, and for his sustained contributions to the field of cellular immunology.
  • 2020: Stuart H. Orkin, MD, Harvard University, for breakthrough discoveries on red blood cells that offer new treatments for patients with sickle cell disease and beta-thalassemia, which are among the most common genetic disorders.
  • 2021: Jointly awarded to Warren J. Leonard, MD, NHLBI and John J. O’Shea, MD,  NIAMS, NIH, for their respective contributions to the field of immunology, from fundamental discovery to therapeutic impact.

For questions or more information about the nomination requirements, visit HarringtonDiscovery.org/ThePrize or contact Bronwyn Monroe, Harrington Discovery Institute Program Director, at Bronwyn.Monroe@HarringtonDiscovery.org.